The company said it launched and priced an underwritten offering of 13,000,000 shares of common stock on February 15, 2024 at a public offering price of $82.25 per share ($80.605 per share, net of underwriting discount).

1. 01

   The company said it launched and priced an underwritten offering of 13,000,000 shares of common stock on February 15, 2024 at a public offering price of $82.25 per share ($80.605 per share, net of underwriting discount).

2. 02

   GE HealthCare Technologies said it is not selling any common stock and will not receive any proceeds from the sale of the GEHC Shares in the offering or from the debt-for-equity exchange.

3. 03

   The company said General Electric Company (GE) is expected to exchange the GEHC Shares for GE indebtedness held by Morgan Stanley Senior Funding, Inc. and Morgan Stanley Bank, N.A. before the offering closes, and that Morgan Stanley & Co. LLC plans to sell the shares to the underwriters as selling stockholder.

4. 04

   It said the selling stockholder granted the underwriters an option to buy additional GEHC shares at the public offering price less the underwriting discount for 30 days. The Underwriting Agreement dated February 15, 2024 names Morgan Stanley & Co. LLC and BofA Securities, Inc. as representatives of the underwriters.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.